MedPath

Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure Treated With Bilevel Positive Airway Pressure as Second-line Therapy.

Terminated
Conditions
Obstructive Sleep Apnea
Registration Number
NCT02930460
Lead Sponsor
ResMed
Brief Summary

Prospective observational study of obstructive Sleep Apnea patients treated with Bilevel Positive Airway Pressure: AirCurve 10 VAutoTM

Detailed Description

To characterize, in routine practice, non compliant patient to continuous positive airway pressure who can get a benefit of a bilevel positive airway pressure therapy as a second line treatment (Aircurve 10 VAutoTM ) To evaluate the clinical management of obstructive sleep apnea patients treated by Aircurve 10 VAutoTM , especially impact on compliance and residual apnea hypopnea Index.

To evaluate Aircurve 10 VAutoTM benefit on quality of Life and quality of sleep

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adult patient
  • Obstructive Sleep Apnea Patient previously treated by Continuous positive airway pressure non-compliant to therapy
  • Patient naive of bilevel Positive Airway Pressure therapy
Exclusion Criteria
  • Bilevel positive airway pressure Contraindication
  • Severe respiratory disease diagnostic

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compliance3 months

hours of usage of the device per night

Secondary Outcome Measures
NameTimeMethod
sleepiness3 months

Epworth sleepiness score evolution

sleep quality3 months

Pittsburgh sleep questionnaire index

Trial Locations

Locations (8)

CH de Belfort

🇫🇷

Belfort, France

Clinique Aguilera

🇫🇷

Biarritz, France

Cabinet de Pneumologie

🇫🇷

Blois, France

HCL - Croix-Rousse Hospital

🇫🇷

Lyon, France

APHM

🇫🇷

Marseille, France

Centre médical du sommeil

🇫🇷

Metz, France

Hopital Saint Antoine

🇫🇷

Paris, France

Polyclinique Saint-Laurent

🇫🇷

Rennes, France

CH de Belfort
🇫🇷Belfort, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.